Purchase Order 75N91025P00043

Award Date 10/29/24
Potential Completion Date 12/31/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Santa Clara, CA 95050, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order contract, valued at $13,594.30, was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Cyagen Biomodels LLC, a for-profit biotechnology company located in Santa Clara, California. The contract is for the generation of a TBX3 conditional knockout mouse strain to support biomedical research. No small business set-aside was used for this award. Cyagen Biomodels LLC specializes in...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,971.50 firm fixed price purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185806). As the prime contractor, Cyagen Biomodels LLC will deliver the requested mouse models from its facility in Santa Clara, California under the terms of this contract over a six-month period concluding in March 2024. The award...
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
This firm-fixed-price purchase order was awarded to Ingenious Targeting Laboratory Inc., a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business, to provide services related to creating conditional knockout mice. The $24,850.00 contract was awarded by the Department of Health and Human Services (HHS) and covers activities such as generating a targeting vector and embryonic stem (ES) cells, clone screening, blastocyst injection, mouse breeding, and...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Taconic Biosciences, Inc. (doing business as SAS Supply) to provide laboratory mice. The contract is a firm fixed price delivery order with a ceiling value of $51,357.00 and a period of performance through June 30, 2024. Taconic Biosciences is the prime contractor on this award and has not subcontracted any...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,000 purchase order to Cyagen Biomodels LLC for conditional knockout mouse model services (Ambis #2185291). Under the firm fixed price contract, Cyagen Biomodels LLC will deliver conditional knockout mouse models to support the NIH's research efforts from its facility in Santa Clara, California. The contract term runs from September 6, 2023 through...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ingenious Targeting Laboratory Inc. The contract is valued at $31,245.00 and has a completion date of December 31, 2013. The contract is for the provision of ROSA26 knock-in mice, which are genetically modified mouse models used in biomedical research. The contract was set aside for small businesses, and Ingenious...
This federal contract award to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California, is for the replacement of a previous purchase order from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $30,915.00 firm-fixed-price purchase order does not have a set-aside designation. Cyagen Biomodels LLC specializes in providing custom genetic model services to support biomedical research, including the creation of...
This federal contract award is for a delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $7,286.00, is for additional breeding and other services to support gene targeting,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cyagen Biosciences Inc., a self-certified small disadvantaged business. The $16,950.00 firm-fixed price purchase order is for "CYAGEN BIOSCIENCE DOUBLE KNOCKOUT MOUSE PRODUCTION" services. The contract does not have a set-aside designation and is set to conclude on September 15, 2014. Cyagen Biosciences Inc. is the prime contractor, and no major...

This federal contract award, valued at $13,594.30, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract was awarded to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California, to perform in vivo mouse experiments using the TMPRSS2 flox strain. The goal is to study the function and underlying mechanism of the TMPRSS2 protein under the intestinal mucosal system. This contract is a firm-fixed-price purchase order with a period of performance ending on December 31, 2024. There is no set-aside designation for this award.

Generated 11/7/24, 9:02 AM